Thursday, November 26, 2015

Tengion to cut back in Phila. region as focus moves to N.C.

The Montgomery County biotechnology firm will eliminate 30 employees, or 58 percent of its workforce.

Tengion to cut back in Phila. region as focus moves to N.C.


Tengion Inc., one of the most innovative life-sciences companies to call the Philadelphia region home, is in full restructuring mode.

When it is done, the company will have far more presence in North Carolina than in Montgomery County where its corporate headquarters has been located since its founding.

Tengion said it will cut 30 employees, or about 58 percent of its workforce. All research and development functions will be moved to its Winston-Salem, N.C. location.

As for its East Norriton headquarters, Tengion said it will "retain a limited number of administrative employees" there as it considers option for cutting the amount of space it rents there.

Tengion is a biotechnology firm that has been trying to commercialize a process to regenerate organs. As part of its restructuring, the company said it will focus on Phase 1 clinical trials for its Neo-Urinary Conduit" product.

All of the moves are aimed at providing enough cash for Tengion to continue operating through November 2012, the company said.

In late June, Tengion CEO Steven A. Nichtberger resigned and he was replaced by the company's chairman, David I. Scheer. Earlier this year, Medtronic invested $31.4 million in Tengion. UPDATE: Earlier this year, Medtronic provided about $7 million in a private placement that raised about $30 million for Tengion.

Founded in 2003, Tengion went public at $5 per share in April 2010. As of the early afternoon, shares were trading at 53 cents, up 3 cents per share, or 5 percent.

Inquirer Columnist
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
Mike Armstrong blogs about Philadelphia corporations and business-related topics. Contact him at 215-854-2980. Reach Mike at

Mike Armstrong Inquirer Columnist
Also on
letter icon Newsletter